Xarelto 20 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F73TR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,680
Award facts
- Contract value 100% obligated
- $14,679.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of Xarelto 20 mg tablets (90-count packages) under a firm fixed-price contract valued at $14,679.62, with completion scheduled for January 8, 2026. This delivery order is a child contract executed under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.99 billion vehicle running through December 2026 that serves as a comprehensive global pharmaceutical support platform for military healthcare programs. The award involved no set-aside designation, indicating full and open competition.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor within the federal medical procurement ecosystem, with demonstrated capability to fulfill diverse pharmaceutical supply requirements across multiple therapeutic domains. The delivery order represents a routine task order execution under the broader IDC vehicle, supporting the Defense Health Agency and other military healthcare systems with essential prescription medications. Xarelto (rivaroxaban) is an anticoagulant used in military and veteran healthcare settings for thromboembolism prevention and treatment, reflecting DLA's consistent procurement patterns for specialty pharmaceutical products through this established prime vendor relationship.
Quick answers
Who was awarded contract SPE2DR26F73TR?
SPE2DR26F73TR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26F73TR worth?
The government has obligated $14,680 on SPE2DR26F73TR.
Is contract SPE2DR26F73TR an order under another contract?
Yes. SPE2DR26F73TR is a delivery order under SPE2DR25D1202, an indefinite delivery contract.
Was contract SPE2DR26F73TR competed?
The extent of competition for SPE2DR26F73TR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award